Brookline, MA, United States of America

Keizo Kova

This inventor holds 1 USPTO granted patent. Top assignee: Synta Pharmaceuticals Corporation. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keizo Kova. Retrieved from https://idiyas.com/inventor/keizo-kova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keizo Kova: Innovator in Pharmaceutical Chemistry

Introduction

Keizo Kova is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of taxol enhancers. His innovative work has implications for cancer treatment and drug development.

Latest Patents

Kova holds a patent for the "Synthesis of taxol enhancers." This patent discloses a method of preparing a thiohydrazide product compound from a hydrazide starting compound. The method involves reacting the starting compound with a thionylating reagent, leading to the formation of a thiohydrazide product compound. This innovation is crucial for enhancing the efficacy of taxol, a well-known anti-cancer drug.

Career Highlights

Kova is associated with Synta Pharmaceuticals Corporation, where he applies his expertise in pharmaceutical research. His work focuses on developing new methods and compounds that can improve therapeutic outcomes for patients. With 1 patent to his name, Kova has established himself as a valuable contributor to the field.

Collaborations

Some of Kova's coworkers include Shoujun Chen and Lijun Sun. Their collaborative efforts in research and development have further advanced the goals of their organization.

Conclusion

Keizo Kova's innovative work in the synthesis of taxol enhancers showcases his commitment to improving cancer treatment options. His contributions to pharmaceutical chemistry are noteworthy and continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…